JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES) ›› 2017, Vol. 55 ›› Issue (7): 89-94.doi: 10.6040/j.issn.1671-7554.0.2016.1307

Previous Articles     Next Articles

Significance of lymphocytes and DSA monitoring for acute rejection diagnosis on the early stage of kidney transplantation

ZHENG Jin, ZHANG Jiangwei, WANG Xuzhen, KUANG Peidan, HE Xiaoli, XUE Wujun   

  1. Department of Kidney Transplant, Hospital of Nephrology, the First Affiliated Hospital of Xian Jiaotong University, Xian 710061, Shaanxi, China
  • Received:2016-10-14 Online:2017-07-10 Published:2017-07-10

PDF (PC)

324

Abstract: Objective To analyze and monitor lymphocytes ratio, donor specificity antibodies(DSA)and non-donor specificity antibodies(NDSA)levels for acute rejection(AR)diagnosis on the early stage of kidney transplantation. To provide reliable basis for clinical prevention of rejection reaction, early diagnosis of rejection, formulate reasonable individualized immunosuppressive therapy and evaluate therapeutic effect. Methods A total of 454 patients who accepted kidney transplantation in our department from January 2014 to June 2016 were enrolled in this study. Recipients lymphocytes ratio, DSA, and NDSA were monitored with flow cytometry and Luminex. Data were analyzed statistically by SPSS17.0 software. Results Within 6 months after transplantation, 33 cases(7.3%)occurred AR(AR group)and 421 cases had stable allograft function(SF group). The CD4+T/CD8+T ratio(2.81±0.85 vs 1.39±0.94, t=7.336, P<0.001)and B cell percentage［(15.79±3.53)% vs(10.2±3.04)%, t=4.986, P<0.001］ were significantly higher in the AR group than the SF group. The HLA antibody medium fluorescent intensity(MFI)of the AR group was gradually increased one week after transplantation and had an obviously difference with that of the SF 山 东 大 学 学 报 (医 学 版)55卷7期 -郑瑾,等.肾移植术后早期淋巴细胞及DSA监测在诊断移植排斥反应中的意义 \=-group(P<0.05). The average value of MFI was 7 559±1 496 in the AR group and it was decreased statistically after treatment(5 023±996)(t=13.853, P<0.001). AR occurrence was 3.1%(11/357)and 14.5%(12/83)in DSA-/NDSA- and DSA-/NDSA+ recipients, respectively. For DSA+/NDSA+ recipients, AR occurrence was 71.4%(10/14)which was significantly higher than DSA-/NDSA- and DSA-/NDSA+ recipients(P<0.001). Conclusion Monitoring CD4+T/CD8+T ratio, B lymphocyte percentage and serum DSA/NDSA levels could assist in the diagnosis and the early warning of AR.

Key words: Lymphocyte, Non-donor specificity antibodies, Renal transplant, Immune state monitoring, Donor specificity antibodies

CLC Number: 

  • R392.4
[1] Wang JH, Skeans MA, Israni AK. Current status of kidney transplant outcomes:dying to survive[J]. Adv Chronic Kidney Dis, 2016, 23(5): 281-286.
[2] Nashan B. Is acute rejection the key predictor for long-term outcomes after renal transplantation when comparing calcineurin inhibitors?[J]. Transplant Rev, 2009, 23(1):47-52.
[3] McKeown-Eyssen GE, Guttmann RD. Factors associated with outcome of renal transplantation[J]. Can Med Assoc J, 1983, 129(11): 1195-1199.
[4] Haas M. The revised(2013)Banff Classification for antibody-mediated rejection of renal allografts: update, difficulties, and future considerations[J]. Am J Transplant, 2016, 16(5):1352-1357.
[5] Strom TB, Garovoy MR. Clinical and experimental aspects of renal allograft rejection[J]. Am J Kidney Dis, 1981, 1(1): 5-14.
[6] Kanzaki G, Shimizu A. Currently available useful immunohistochemical markers of renal pathology for the diagnosis of renal allograft rejection[J]. Nephrology, 2015, 20(2):9-15.
[7] Little CC, Tyzzer EE. Further experimental studies on the inheritance of susceptibility to a transplantable tumor, carcinoma(J. W. A.)of the Japanese waltzing mouse[J]. J Med Res, 1916, 33(3): 393-453.
[8] Little CC. The heredity of susceptibility to a transplantable sarcoma(J. W. B.)of the Japanese waltzing mouse[J]. Science, 1920, 51(1323): 467-468.
[9] Suthanthiran M, Strom TB. Mechanisms and management of acute renal allograft rejection[J]. Surg Clin North Am, 1998, 78(1):77-94.
[10] Davis S, Cooper JE. Acute antibody-mediated rejection in kidney transplant recipients[J]. Transplant Rev, 2017, 31(1):47-54.
[11] Bravo Soto JA, Esteban de la Rosa RJ, Luna del Castillo JD, et al. Effect of mycophenolate mofetil regimen on peripheral blood lymphocyte subsets in kidney transplant recipients[J]. Transplant Proc, 2003, 35(4): 1355-1359.
[12] Ordonez L, Bernard I, Chabod M, et al. A higher risk of acute rejection of human kidney allografts can be predicted from the level of CD45RC expressed by the recipients’ CD8 T cells[J]. PLoS One, 2013, 8(7): e69791. doi: 10.1371/journal.pone.0069791.
[13] Rajalingam R. The impact of hla class I-specific killer cell immunoglobulin-like receptors onantibody-dependent natural killer cell-mediated cytotoxicity and organ allograft rejection[J]. Front Immunol, 2016, 7:585. doi: 10.3389/fimmu.2016.00585.
[14] McKenna RM, Takemoto SK, Terasaki PI. Anti-HLA antibodies after solid organ transplantation[J]. Transplantation, 2000, 69(3): 319-326.
[15] Djamali A, Kaufman DB, Ellis TM, et al. Diagnosis and management of antibody-mediated rejection: current status and novel approaches[J]. Am J of Transplant, 2014,14(2): 255-271.
[16] Ginevri F, Nocera A, Comoli P, et al. Posttransplant de novo Donor-Specific HLA antibodies identify pediatric kidney recipientsat risk for late antibody-mediated rejection[J]. Am J of Transplant, 2012, 12(12): 3355-3362.
[17] Salvadori M, Bertoni E. Impact of donor-specific antibodies on the outcomes of kidney graft: pathophysiology, clinical, therapy[J]. World J Transplant, 2014, 24(1): 1-17.
[18] Harmer AW, Koffman CG, Heads AJ, et al. Sensitization to HLA antigens occurs in 95% of primary renal transplant rejections[J]. Transplant Proc, 1995, 27(1): 666-667.
[19] El-Awar N, Terasaki P, Lazda V, et al. Almost all patients who are waiting for a regraft of a kidney transplant have anti-HLA antibodies[J]. Transplant Proc, 2002, 34(7): 2531-2532.
[20] Zheng J, Xue W, Jing X, et al. Influence of de novo donor-specific antibody on early renal allograft function recovery[J]. Ren Fail, 2015, 37(3): 462-468.
[21] 郑瑾,薛武军,景鑫,等. 供者特异性抗体监测在肾脏移植中的应用[J]. 中华移植杂志(电子版), 2014, 8(3): 133-137. ZHENG Jin, XUE Wujun, JING Xin, et al. Donor specific antibodies monitoring in the kidney transplantation[J]. Chin J Transplant(Electronic Edition), 2014, 8(3): 133-137.
[22] Freitas MC, Rebellato LM, Ozawa M, et al. The role of immunoglobulin-G subclasses and C1q in de novo HLA-DQ donor-specific antibody kidney transplantation outcomes[J]. Transplantation, 2013, 95(9): 1113-1119.
[23] Thammanichanond D, Mongkolsuk T, Rattanasiri S, et al. Significance of C1q-fixing donor-specific antibodies after kidney transplantation[J]. Transplant Proc, 2014, 46(2): 368-371.
[24] Sacks SH, Zhou W. The role of complement in the early immune response to transplantation[J]. Nat Rev Immunol, 2012, 12(6): 431-442.
[25] 杨勇,王伟,司晶,等. 供者特异性抗体在肾移植中的诊治进展[J]. 武汉大学学报(医学版), 2016, 37(4): 640-646. YANG Yong, WANG Wei, SI Jing, et al. Current diagnosis and therapy states of donor specific antibodies in kidney transplantation[J]. Medical Journal Wuhan University, 2016, 37(4): 640-646.
[26] Alexandre L, Carmen L, Dewi V, et al. Complement-binding anti-HLA antibodies and kidney-allograft survival[J]. N Engl J Med, 2013, 369(13): 1215-1227.
[27] Haas M. The revised(2013)Banff classification for antibody-mediated rejection of renal allografts: update, difficulties, and future considerations[J]. Am J Transplant, 2016, 16(5): 1352-1357.
[28] Loupy A, Haas M, Solez K, et al. The Banff 2015 kidney meeting report: current challenges in rejection classification and prospects for adopting molecular pathology[J]. Am J Transplant, 2017, 17(1): 28-41.
[1] WANG Wen, LIU Yao, LONG Fei, MA Weixia, SU Lili. Correlation between lymphocyte-to-monocyte ratio in peripheral blood and prognosis of malignant pleural mesothelioma [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2016, 54(8): 72-77.
[2] XU Zhihong, LIU Rongfeng, WANG Xiaoxiang, FENG Li, YAO Tiezhu, LIU Hong. Efficacy and safety of Yangzheng Xiaoji capsule combined with chemotherapy in treating metastatic breast cancer [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2016, 54(5): 79-83.
[3] NIU Ruifang1, ZHANG Chunling2, ZHAI Yaping3,MA Yuehua3, LI Xiaoling3, ZHAO Zhigang3. Effects of short-term treatment of Tripterygium wilfordii polyglycosidium on T-lymphocyte subsets in thyroid tissue of Hashimoto′s disease [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2014, 52(3): 86-89.
[4] SUN Yuan-xin1, QIN Xue-mei1, LIU Xi-min2, WANG Li-zhi2, LIU Chuan-fang1, LIU Lu1. Relationship between regulatory T cells, IL-35 and aGVHD after allo-HSCT [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2013, 51(3): 89-94.
[5] LIU Ying1, LI Xiao-li1, XU Hua2, WANG Shan1, ZHANG Min1, LI Heng1, DUAN Rui-sheng1. Effects of lower dose of atorvastatin on experimental autoimmune myasthenia gravis inrats [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2012, 50(7): 26-31.
[6] ZHENG Rong-hua, SHI Yu-hua, SHENG Yan, GAO Qin, GAO Xuan, CHEN Zi-Jiang . Changing Characteristics of peripheral white blood cell counts in patients with polycystic ovary syndrome [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2012, 50(7): 78-80.
[7] ZHOU Bing-xia1, GUO Shu-lan1， XU yan-jing2. Expression and significance of FOXP3 in pityriasis rosea, lichen
 planus, large-plaque parapsoriasis and mycosis fungoides [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2012, 50(2): 102-105.
[8] ZHU Yue-ting1， JIAO Yu-lian2， CUI Bin2， ZHANG Jie2， YOU Li2， ZHAO Yue-ran1,2. Expression of the fusion protein of human soluble B lymphocyte stimulator  and diphtheria toxin in E.coli and its biological activity [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2011, 49(7): 48-52.
[9] HAO Xiao-rui， LU Xue-feng， SUN Na， LIU Sheng-nan， LIU Liang. Expression of decoy receptor 3 in esophageal squamous cell carcinoma and  its correlation with tumor infiltrating T lymphocytes [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2011, 49(6): 134-.
[10] CAO Xia, WANG Lian-lian, LUO Xi. Expression of regulatory T cells and helper T lymphocytes in the peripheral  blood of pregnancy induced hypertension women [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2011, 49(6): 137-139.
[11] WU Yan， HUI Fu-xin， ZHAO Yin-ying， FAN Xiao-dong, BIAN Tao. Effect of virus infections on T lymphocyte subsets in patients with chronic obstructive pulmonary disease [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2011, 49(11): 117-.
[12] ZHANG Dong1, HE Hai-xian2, DONG Li-xin3, CHEN Zhenggang4, WANG Yu-min1, LIU Shao-hua1. Expression of Galectin-1 in squamous cell carcinoma of the tongue and correlation with clinicopathological parameters [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2011, 49(11): 138-.
[13] XU Yanjing, GUO Shulan. Expression and significance of FOXP3 in normal skin and epidermis neoplasms [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2010, 48(3): 149-151.
[14] CAI Rui， TAN Xiao-dong. Roles of Th17interrelated cytokines in experimental allergic neuritis [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2010, 48(3): 61-65.
[15] ZHOU Yuhai, ZHAO Shengtian, YUAN Mingzhen, ZHANG Xufeng,CHEN Yougen, HUANG Shengliang. Expressions of Th17 lymphocytes related cytokines in experimental autoimmune prostatitis tissue [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2010, 48(2): 63-66.
Viewed
Full text


Abstract

Cited
  Shared   
  Discussed   
No Suggested Reading articles found!
Copyright 2018 © Editorial office of Journal of Shandong University (Health Sciences)
Supported by Beijing Magtech Co.Ltd